Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone in OCD
NCT03348930Phase 3Completed
- Sponsor
- University of Chicago
- Start
- Mar 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolcapone in obsessive compulsive disorder (OCD), sponsored by University of Chicago. Started Mar 2018; status: completed.
02
Drugs
tolcapone
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT03348930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03348930.